Literature DB >> 21977361

Why does mommy forget?

Roy Yaari, Adam S Fleisher, Anna D Burke, Helle Brand, Jan Dougherty, James D Seward, Pierre N Tariot.   

Abstract

Year:  2011        PMID： 21977361      PMCID： PMC3184598          DOI： 10.4088/PCC.11alz01158

Source DB:  PubMed          Journal:  Prim Care Companion CNS Disord        ISSN： 2155-7780


× No keyword cloud information.
  12 in total

Review 1.  In-office mental status testing: a practical guide.

Authors:  D Mungas
Journal:  Geriatrics       Date:  1991-07

2.  Decreased cerebrospinal fluid Abeta(42) correlates with brain atrophy in cognitively normal elderly.

Authors:  Anne M Fagan; Denise Head; Aarti R Shah; Daniel Marcus; Mark Mintun; John C Morris; David M Holtzman
Journal:  Ann Neurol       Date:  2009-02       Impact factor: 10.422

3.  Prevalence of primitive reflexes and Parkinsonian signs in dementia.

Authors:  K A Links; D Merims; M A Binns; M Freedman; T W Chow
Journal:  Can J Neurol Sci       Date:  2010-09       Impact factor: 2.104

4.  EFNS guidelines for the diagnosis and management of Alzheimer's disease.

Authors:  J Hort; J T O'Brien; G Gainotti; T Pirttila; B O Popescu; I Rektorova; S Sorbi; P Scheltens
Journal:  Eur J Neurol       Date:  2010-10       Impact factor: 6.089

5.  Levels of nonphosphorylated and phosphorylated tau in cerebrospinal fluid of Alzheimer's disease patients : an ultrasensitive bienzyme-substrate-recycle enzyme-linked immunosorbent assay.

Authors:  Yuan Yuan Hu; Shan Shu He; Xiaochuan Wang; Qiu Hong Duan; Inge Grundke-Iqbal; Khalid Iqbal; Jianzhi Wang
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

6.  Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  D S Knopman; S T DeKosky; J L Cummings; H Chui; J Corey-Bloom; N Relkin; G W Small; B Miller; J C Stevens
Journal:  Neurology       Date:  2001-05-08       Impact factor: 9.910

7.  Biochemical diagnosis of Alzheimer disease by measuring the cerebrospinal fluid ratio of phosphorylated tau protein to beta-amyloid peptide42.

Authors:  Alessia Maddalena; Andreas Papassotiropoulos; Britta Müller-Tillmanns; Hans H Jung; Thomas Hegi; Roger M Nitsch; Christoph Hock
Journal:  Arch Neurol       Date:  2003-09

8.  Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects.

Authors:  Leslie M Shaw; Hugo Vanderstichele; Malgorzata Knapik-Czajka; Christopher M Clark; Paul S Aisen; Ronald C Petersen; Kaj Blennow; Holly Soares; Adam Simon; Piotr Lewczuk; Robert Dean; Eric Siemers; William Potter; Virginia M-Y Lee; John Q Trojanowski
Journal:  Ann Neurol       Date:  2009-04       Impact factor: 10.422

9.  Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study.

Authors:  Harald Hampel; Katharina Buerger; Raymond Zinkowski; Stefan J Teipel; Alexander Goernitz; Niels Andreasen; Magnus Sjoegren; John DeBernardis; Daniel Kerkman; Koichi Ishiguro; Hideto Ohno; Eugeen Vanmechelen; Hugo Vanderstichele; Cheryl McCulloch; Hans-Jurgen Moller; Peter Davies; Kaj Blennow
Journal:  Arch Gen Psychiatry       Date:  2004-01

Review 10.  Molecular genetics of Alzheimer's disease.

Authors:  Pau Pastor; Alison M Goate
Journal:  Curr Psychiatry Rep       Date:  2004-04       Impact factor: 5.285
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.